Cargando…
Correction: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188469/ https://www.ncbi.nlm.nih.gov/pubmed/26585835 http://dx.doi.org/10.1038/ncomms10054 |
| _version_ | 1783527318983016448 |
|---|---|
| author | Wee, Zhen Ning Yatim, Siti Maryam J. M. Kohlabauer, Vera K. Feng, Min Goh, Jian Yuan Bao, Yi Lee, Puay Leng Zhang, Songjing Wang, Pan Pan Lim, Elgene Tam, Wai Leong Cai, Yu Ditzel, Henrik J. Hoon, Dave S. B. Tan, Ern Yu Yu, Qiang |
| author_facet | Wee, Zhen Ning Yatim, Siti Maryam J. M. Kohlabauer, Vera K. Feng, Min Goh, Jian Yuan Bao, Yi Lee, Puay Leng Zhang, Songjing Wang, Pan Pan Lim, Elgene Tam, Wai Leong Cai, Yu Ditzel, Henrik J. Hoon, Dave S. B. Tan, Ern Yu Yu, Qiang |
| author_sort | Wee, Zhen Ning |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7188469 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71884692020-04-28 Correction: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel Wee, Zhen Ning Yatim, Siti Maryam J. M. Kohlabauer, Vera K. Feng, Min Goh, Jian Yuan Bao, Yi Lee, Puay Leng Zhang, Songjing Wang, Pan Pan Lim, Elgene Tam, Wai Leong Cai, Yu Ditzel, Henrik J. Hoon, Dave S. B. Tan, Ern Yu Yu, Qiang Nat Commun Erratum Nature Publishing Group UK 2015-11-20 /pmc/articles/PMC7188469/ /pubmed/26585835 http://dx.doi.org/10.1038/ncomms10054 Text en © Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2015 This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Erratum Wee, Zhen Ning Yatim, Siti Maryam J. M. Kohlabauer, Vera K. Feng, Min Goh, Jian Yuan Bao, Yi Lee, Puay Leng Zhang, Songjing Wang, Pan Pan Lim, Elgene Tam, Wai Leong Cai, Yu Ditzel, Henrik J. Hoon, Dave S. B. Tan, Ern Yu Yu, Qiang Correction: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel |
| title | Correction: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel |
| title_full | Correction: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel |
| title_fullStr | Correction: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel |
| title_full_unstemmed | Correction: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel |
| title_short | Correction: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel |
| title_sort | correction: corrigendum: irak1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188469/ https://www.ncbi.nlm.nih.gov/pubmed/26585835 http://dx.doi.org/10.1038/ncomms10054 |
| work_keys_str_mv | AT weezhenning correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT yatimsitimaryamjm correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT kohlabauerverak correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT fengmin correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT gohjianyuan correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT baoyi correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT leepuayleng correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT zhangsongjing correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT wangpanpan correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT limelgene correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT tamwaileong correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT caiyu correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT ditzelhenrikj correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT hoondavesb correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT tanernyu correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel AT yuqiang correctioncorrigendumirak1isatherapeutictargetthatdrivesbreastcancermetastasisandresistancetopaclitaxel |